We are live on ! Find out more
A

Abingworth Portfolio holdings

AUM $307M
1-Year Est. Return 93.47%
This Fund
S&P 500
This Quarter Est. Return
-5.66%
1 Year Est. Return
+93.47%
3 Year Est. Return
+184.38%
5 Year Est. Return
+342.7%
10 Year Est. Return
–
AUM
$133M
AUM Growth
-$42.8M
Cap. Flow
-$125
Cap. Flow %
-0%
Top 10 Hldgs %
99.93%
Holding
11
New
–
Increased
–
Reduced
2
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$122
2
ZLCS
ZALICUS INC COM NEW
ZLCS
+$3

Sector Composition

Rank Sector Weight
1 Healthcare 53.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTLA
1
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$32M 24.08%
1,240,912
-5
-0% -$122
RNA
2
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
$29M 21.82%
6,213,924
– –
SUPN icon
3
Supernus Pharmaceuticals
SUPN
$2.78B
$27.1M 20.43%
3,600,000
– –
AMRN
4
Amarin Corp
AMRN
$292M
$15.9M 11.95%
404,374
– –
CEMP
5
DELISTED
Cempra, Inc.
CEMP
$8.85M 6.67%
714,285
– –
ZGNX
6
DELISTED
Zogenix, Inc.
ZGNX
$8.01M 6.04%
291,902
– –
ACHV icon
7
Achieve Life Sciences
ACHV
$667M
$5.04M 3.79%
274
– –
GWPH
8
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$4.25M 3.2%
102,200
– –
ANTH
9
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$1.34M 1.01%
54,749
– –
HPTX
10
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$1.26M 0.95%
62,500
– –
ZLCS
11
DELISTED
ZALICUS INC COM NEW
ZLCS
$87K 0.07%
78,966
-1
-0% -$3

Similar funds

AAM
Arabesque Asset Management London, United Kingdom $296M AUM 15.19% 1-Year Est. Return
EP
Equius Partners Novato, California $324M AUM 8.27% 1-Year Est. Return
LDFR
Lehman & Derafelo Financial Resources Media, Pennsylvania $337M AUM 8.16% 1-Year Est. Return
MPAM
Monarch Partners Asset Management Boston, Massachusetts $339M AUM 2.52% 1-Year Est. Return
MAG
Mass Ave Global New York $342M AUM 20.58% 1-Year Est. Return
CDIA
Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return
GTCM
Gyon Technologies Capital Management Denville, New Jersey $267M AUM 11.62% 1-Year Est. Return
ACMV
August Capital Management VII Palo Alto, California $265M AUM 26.86% 1-Year Est. Return

Abingworth's Q4 2013 Portfolio in Review

As of Q4 2013, Abingworth held 11 positions worth $133M, down 24% from $175M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2013: portfolio turnover was 0%. Abingworth opened no new positions and made no exits, leaving the 11-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 56% a quarter earlier.

  • Abingworth's biggest Q4 2013 reduction was Portola Pharmaceuticals, Inc., cutting an estimated $122.
  • Abingworth's ten largest holdings make up 100% of its $133M portfolio in Q4 2013.
  • Abingworth opened 0 new positions and closed 0 in Q4 2013.
  • Abingworth's portfolio value fell 24% quarter-over-quarter to $133M.

Based on Abingworth's 13F filing for Q4 2013, filed 14 Feb 2014.